Mississippi House Bill HB410

Mississippi 2022 Regular Session

• Introduced: 1/5/22
• Refer: 1/5/22
• Failed: 2/1/22

Caption

Hypodermic syringes or needles; unlawful to sell, obtain, purchase or possess as a direct consumer without a written prescription.

Impact

The bill specifically addresses the public health implications surrounding the use of hypodermic syringes and needles, particularly in relation to the prevention of blood-borne diseases. By requiring a prescription for the purchase of these items, the legislation aims to deter illicit drug use and reduce the risks associated with unsafe injection practices. Importantly, those selling these items must maintain records of all transactions, retaining prescriptions for a minimum of five years for regulatory oversight.

Summary

House Bill 410 aims to regulate the sale and possession of hypodermic syringes and needles in Mississippi. Under this legislation, it is unlawful for any person to sell or furnish these items to direct consumers without a written prescription from a licensed practitioner. Additionally, individuals are prohibited from purchasing, obtaining, or possessing hypodermic syringes or needles unless they possess a valid prescription. This measure is aimed at controlling drug use and enhancing public health safety concerning injection practices.

Contention

While proponents of HB410 argue that this regulation is essential to preventing drug misuse and promoting health safety, critics may view it as an overreach that could inhibit access for patients who legitimately require hypodermic syringes for medical purposes, like diabetic individuals. The requirement for a prescription may create barriers to obtaining necessary medical supplies and could lead to increased safety issues if patients are unable to access syringes when they need them. Possible discrepancies in implementation and enforcement of these regulations are also points of contention.